Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Allergan plc    AGN   IE00BY9D5467

ALLERGAN PLC

(AGN)
  Report  
Delayed Quote. Delayed Nyse - 08/22 06:30:00 pm
160.93 USD   -0.20%
08/22ALLERGAN : Form 8.3 -
DJ
08/21ABBVIE : Form 8.3 -
DJ
08/20ALLERGAN : Form 8.3 -
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations
Sector news Pharmaceuticals - NEC
02:52aGLAXOSMITHKLINE : GSK drug boosts response rates in blood cancer patients - stud..
RE
02:48aNOVARTIS : Delay on Data Manipulation Probed
DJ
02:29aGLAXOSMITHKLINE : Achieves Positive Results Blood Cancer Treatment Study
DJ
08/22Alexion Up Nearly 8%, on Pace for Largest Percent Increase Since April 2018 -..
DJ
08/22ABBVIE : Form 8.3 -
DJ
08/22EXPLAINER : What are the obstacles to Bayer settling Roundup lawsuits?
RE
08/22SAMSUNG ELECTRONICS : South Korea's top court to rule on Samsung heir's bribery ..
RE
08/22SAMSUNG ELECTRONICS : South Korea's top court to rule on Samsung heir's bribery ..
RE
08/22GSK's long acting HIV injection gets boost from study
RE
08/22MYLAN : Denmark's Novo Nordisk files lawsuit against Mylan over patent
RE
08/22ASTRAZENECA : China Partner Granted Marketing Authorization for Anemia Drug
DJ
08/22GLAXOSMITHKLINE : ViiV Healthcare Reports Positive HIV Trial Results
DJ
08/22ASTRAZENECA : to Buy US FDA Priority Review Voucher for $95 Million
DJ
08/21LONDON STOCK EXCHANGE : Oil majors, exporters boost FTSE 100; Fed minutes eyed
RE
08/21ABBVIE : Form 8.3 -
DJ
08/21PFIZER : Sets $500 Million Gene-Therapy Expansion in Sanford, N.C.
DJ
08/21AstraZeneca Imfinzi combination fails advanced lung cancer study
RE
08/21Slowing Share Buybacks Remove a Pillar of Stock Market
DJ
08/21Bayer Sells Pet-Health Unit for $7.6 Billion -- WSJ
DJ
08/21ASTRAZENECA : Imfinzi, Tremelimumab Combination Didn't Meet Primary Endpoint
DJ
08/20Health Care Lower as Litigation, Deal Risks Linger -- Health Care Roundup
DJ
08/20BAYER : Elanco to become No.2 in animal health with $7.6 billion Bayer deal
RE
08/20BAYER : Elanco to become No.2 in animal health with $7.6 billion Bayer deal
RE
08/20TEVA PHARMACEUTICAL INDUSTRIES : Pharma Shares Up 10% on Release of EpiPen Jr in..
DJ
08/20Bayer to Sell Animal-Health Unit to Elanco for $7.6 Billion -- 2nd Update
DJ
08/20Bayer to Sell Animal-Health Unit to Elanco for $7.6 Billion -- 2nd Update
DJ
08/20Bayer to Sell Animal-Health Unit to Elanco for $7.6 Billion -- Update
DJ
08/20AstraZeneca diabetes drug shows promise in heart failure
RE
08/20BAYER : to Sell Animal Health Unit for $7.6 Billion to Elanco
DJ
08/20ASTRAZENECA : Farxiga Met Primary Endpoint in Landmark Phase 3 Trial
DJ
08/19ALLERGAN : Form 8.3 - Allergan Plc
DJ
08/19NOVARTIS : to answer U.S. Senate demand for data manipulation details
RE
08/19NOVARTIS : CEO Under Fire Over Drug Data
DJ
08/18NOVARTIS : executive sold shares before drug data manipulation made public
RE
08/18NOVARTIS : CEO Battles Fallout From Data Manipulation
DJ
08/16ABBVIE : Gets FDA OK for Rheumatoid Arthritis Drug Rinvoq
DJ
08/16CELGENE : FDA Grants Approval to Celgene's Impact for Bone Marrow Disorder Treat..
DJ
08/16ALLERGAN : Form 8.3 - Allergan Plc
DJ
08/16NOVO NORDISK : contests Danish lawsuit claiming $1.75 billion
RE
08/16Correction to AstraZeneca's Lynparza Clinical Trial Article on Wednesday
DJ
08/15GRAIN HIGHLIGHTS : Top Stories of the Day
DJ
08/15Genentech Receives FDA Accelerated Approval for Cancer Treatment
DJ
08/15Canopy Growth needs another 3-5 years to turn profit
RE
08/15Pfizer Recalls Two Lots of Relpax Over Possible Contamination
DJ
08/14NOVARTIS : Correction to Story on Executive Changes at Novartis
DJ
08/14Canopy Growth revenue misses estimates on lower medical cannabis sales
RE
08/14GRAIN HIGHLIGHTS : Top Stories of the Day
DJ
08/14NOVARTIS : Replaces Two Researchers Amid Data Scandal
DJ
08/14ABBVIE : Form 8.3 - Allergan Plc
DJ
08/14NOVARTIS : names Bulto as new head of U.S. drugs business
RE
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on ALLERGAN PLC